Literature DB >> 19259799

CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.

Cinthya E Díaz-Benítez1, Karla R Navarro-Fuentes, Jacqueline A Flores-Sosa, Janet Juárez-Díaz, Felipe J Uribe-Salas, Edgar Román-Basaure, Ludwig E González-Mena, Patricia Alonso de Ruíz, Guillermina López-Estrada, Alfredo Lagunas-Martínez, Victor H Bermúdez-Morales, Juan M Alcocer-González, Jesús Martínez-Barnetche, Rogelio Hernández-Pando, Yvonne Rosenstein, José Moreno, Vicente Madrid-Marina.   

Abstract

INTRODUCTION: Cervical cancer development from a squamous intraepithelial lesion is thought to be favored by an impaired T cell immunity. We evaluated parameters of T cell alterations such as proliferation, cytokine, and CD3zeta expression in peripheral blood and tumor-infiltrating T lymphocytes from women with squamous intraepithelial lesions (SIL) or cervical cancer (CC). RESULTS AND DISCUSSION: T cell proliferation and cytokine messenger RNA (mRNA) expression were similar in women with SIL and healthy donors, whereas low T cell proliferation and lower mRNA expression of IL-2, IL-10 and IFN-gamma were observed in women with CC. Moreover, infiltrating cells showed marginal responses. We also found that CD3zeta mRNA expression, whose protein is required for T cell activation, correlated with a decreased proliferation in advanced stages of the disease.
CONCLUSION: Experiments with T cells from healthy donors in the presence TGF-beta1 or IL-10 suggest that these cytokines have a relevant role in T cell responses during CC progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19259799     DOI: 10.1007/s10875-009-9279-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  55 in total

1.  A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.

Authors:  S Yamagiwa; J D Gray; S Hashimoto; D A Horwitz
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

2.  Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.

Authors:  I Kuss; T Saito; J T Johnson; T L Whiteside
Journal:  Clin Cancer Res       Date:  1999-02       Impact factor: 12.531

Review 3.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

4.  Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

Authors:  M Clerici; M Merola; E Ferrario; D Trabattoni; M L Villa; B Stefanon; D J Venzon; G M Shearer; G De Palo; E Clerici
Journal:  J Natl Cancer Inst       Date:  1997-02-05       Impact factor: 13.506

5.  High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.

Authors:  Sytse J Piersma; Ekaterina S Jordanova; Mariëtte I E van Poelgeest; Kitty M C Kwappenberg; Jeanette M van der Hulst; Jan W Drijfhout; Cornelis J M Melief; Gemma G Kenter; Gert Jan Fleuren; Rienk Offringa; Sjoerd H van der Burg
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

6.  The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Sylvaine You; Barbara C McGrath; Douglas R Cavener; Carmine Vacca; Ciriana Orabona; Roberta Bianchi; Maria L Belladonna; Claudia Volpi; Pere Santamaria; Maria C Fioretti; Paolo Puccetti
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

7.  Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.

Authors:  T H Inge; K M McCoy; B M Susskind; S K Barrett; G Zhao; H D Bear
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

8.  Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.

Authors:  Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

Review 9.  The role of virus-induced regulatory T cells in immunopathology.

Authors:  Shelly J Robertson; Kim J Hasenkrug
Journal:  Springer Semin Immunopathol       Date:  2006-07-14

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  14 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.

Authors:  Wei Li; Amritha Kidiyoor; Yangyang Hu; Changcheng Guo; Min Liu; Xudong Yao; Yuanyuan Zhang; Bo Peng; Junhua Zheng
Journal:  Tumour Biol       Date:  2014-10-22

Review 3.  Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Zhaojun Shen; Xiaoli Hu; Luzhe Sun; Xueqiong Zhu
Journal:  Tumour Biol       Date:  2016-03-24

4.  Cervical cancer-associated promoter polymorphism affects akna expression levels.

Authors:  G A Martínez-Nava; K Torres-Poveda; A Lagunas-Martínez; M Bahena-Román; M A Zurita-Díaz; E Ortíz-Flores; A García-Carrancá; V Madrid-Marina; A I Burguete-García
Journal:  Genes Immun       Date:  2014-11-06       Impact factor: 2.676

5.  Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade.

Authors:  Seyed Mohammad Miri; Behzad Pourhossein; Seyed Younes Hosseini; Mohsen Keshavarz; Shohreh Shahmahmoodi; Mohammad Reza Zolfaghari; Seyed Reza Mohebbi; Ali Gorji; Amir Ghaemi
Journal:  Virol J       Date:  2022-06-25       Impact factor: 5.913

Review 6.  Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.

Authors:  Kirvis Torres-Poveda; Margarita Bahena-Román; Claudia Madrid-González; Ana I Burguete-García; Víctor Hugo Bermúdez-Morales; Oscar Peralta-Zaragoza; Vicente Madrid-Marina
Journal:  World J Clin Oncol       Date:  2014-10-10

7.  The SNP at -592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development.

Authors:  Kirvis Torres-Poveda; Ana I Burguete-García; Miguel Cruz; Gabriela A Martínez-Nava; Margarita Bahena-Román; Esmeralda Ortíz-Flores; Abrahan Ramírez-González; Guillermina López-Estrada; Karina Delgado-Romero; Vicente Madrid-Marina
Journal:  Infect Agent Cancer       Date:  2012-11-14       Impact factor: 2.965

8.  Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development.

Authors:  E Guzmán-Olea; V H Bermúdez-Morales; O Peralta-Zaragoza; K Torres-Poveda; V Madrid-Marina
Journal:  J Oncol       Date:  2011-12-19       Impact factor: 4.375

9.  Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies.

Authors:  Deep Pandya; Marisa Mariani; Shiquan He; Mirko Andreoli; Manuela Spennato; Candice Dowell-Martino; Paul Fiedler; Cristiano Ferlini
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

10.  T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.

Authors:  Nicolás A Giraldo; Natalia I Bolaños; Adriana Cuellar; Nubia Roa; Zulma Cucunubá; Fernando Rosas; Víctor Velasco; Concepción J Puerta; John M González
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.